 | ||||||||||||||||||||||||||||
KurzfassungThe French company has developed a device for early disgnosis. This device can be used to diagnose several pathologies, such as Parkinson-plus syndromes and multiple sclerosis. Other pathologies are being studied. The French ocmpany is looking for partners to collaborate on different projects: cooperation on new diagnostic of neurological diseases, development of drugs, tests of new drugs...DetailsThe device provides a complete solution including a helmet, a chinrest, a computer and two screens plus the software needed for stimulation and analysis.The whole operation takes around 20 minutes, from the calibration of the device and the examination itself to the analysis of the results. This is a binocular device and utilizes an acquisition frequency of 300 hertz, which enables it to obtain a detailed trace. The society has developed two sophisticated algorithms, one to recognize the pupil and the other to analyze eye movements. This device can be used to diagnose several pathologies, such as Parkinson-plus syndromes and multiple sclerosis. Other pathologies are being studied. Innovative Aspects: The device allows to help diagnose early pathologies like Parkinson plus and multiple scleroses. It is also a good device for monitoring the effect of treatment in various neurological pathologies thanks to a complete and quantitative eye movements check up. The company also proposes to design and develop paradigms adapted to a specific pathology or drug and specific eye trackers for eye movement’s tests.
| ||||||||||||||||||||||||||||
